Florida Research & Innovation Center

Local research, global impact

Who we are

The Florida Research & Innovation Center (FRIC) focuses on basic and translational research related to infectious diseases, inflammatory diseases and cancer. Our research team investigates conditions that disproportionately affect Treasure Coast communities, like lymphomas and insect-transmitted viruses.

What we do

The FRIC is closely integrated with Cleveland Clinic's Sheikha Fatima bint Mubarak Global Center for Pathogen & Human Health Research. We are the primary site of Cleveland Clinic's global vaccine development program, where we work to design and test novel vaccines.

Work with us

Exciting investigations and groundbreaking discoveries happen every day at Cleveland Clinic. We are dedicated to making a regional impact in the communities we serve by hiring local talent and educating the healthcare workforce of the future.

Join our growing team of more than 100 professionals

Explore all labs in Florida Research & Innovation Center

Facilities & Cores

The Florida Research & Innovation Center complements and expands research currently underway at Cleveland Clinic's five Florida hospitals, as well as Cleveland Clinic's Lerner Research Institute in Cleveland, Ohio. Our facilities span approximately 100,000 sq. ft of dedicated research and support spaces, including state-of-the-art shared resource facilities in flow cytometry, imaging and bioinformatics.

Explore Facilities & Cores

Research News

Immune protein modification blocks viral replication, heart inflammation

Protein modifications to the immune sensor MDA5 reduce viral replication and may lead to broad-spectrum antiviral breakthroughs.

Exhausted B cells may reduce flu vaccine effectiveness

Poor flu vaccine responses in people with immature and exhausted memory B cells may grant less effective immunity, but might be treated with improved vaccines.

Discoveries about herpes virus that causes cancer to fuel new vaccines, anti-virals

Drs. Jae Jung and Jun Zhao were awarded $8.3 and $2.3 million each to learn how a herpesvirus causes cancer with the goal of making a herpes vaccine and antiviral.

More News